MANNI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 1.282
AS - Asia 560
EU - Europa 486
SA - Sud America 106
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 2.490
Nazione #
US - Stati Uniti d'America 1.250
SG - Singapore 250
CN - Cina 120
RU - Federazione Russa 117
BR - Brasile 95
IT - Italia 91
HK - Hong Kong 80
SE - Svezia 76
DE - Germania 54
VN - Vietnam 53
GB - Regno Unito 47
CI - Costa d'Avorio 40
FI - Finlandia 20
FR - Francia 20
CA - Canada 19
BE - Belgio 12
ID - Indonesia 12
MX - Messico 11
JP - Giappone 10
IN - India 9
ZA - Sudafrica 9
BD - Bangladesh 8
NL - Olanda 8
PL - Polonia 8
ES - Italia 7
LT - Lituania 7
AR - Argentina 6
TR - Turchia 5
UA - Ucraina 5
IQ - Iraq 3
AL - Albania 2
AT - Austria 2
CL - Cile 2
CZ - Repubblica Ceca 2
EU - Europa 2
JO - Giordania 2
LK - Sri Lanka 2
OM - Oman 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BF - Burkina Faso 1
BG - Bulgaria 1
BJ - Benin 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
IE - Irlanda 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
LV - Lettonia 1
MK - Macedonia 1
PA - Panama 1
RO - Romania 1
SA - Arabia Saudita 1
TN - Tunisia 1
VE - Venezuela 1
Totale 2.490
Città #
Ashburn 202
Fairfield 145
Singapore 135
Chandler 115
Woodbridge 109
Hong Kong 80
Nyköping 61
Seattle 58
Houston 56
Beijing 53
Cambridge 46
Abidjan 40
Wilmington 30
Ann Arbor 29
Los Angeles 28
Munich 23
Ho Chi Minh City 18
New York 18
Bari 16
Lawrence 16
Brooklyn 15
Moscow 15
Roxbury 15
Dallas 14
Helsinki 14
Frankfurt am Main 13
Toronto 13
Brussels 12
Jakarta 12
London 12
Nuremberg 11
São Paulo 11
Des Moines 10
Jacksonville 10
Tokyo 10
Poplar 9
Bisceglie 8
Cagliari 8
Chicago 8
Inglewood 8
Phoenix 8
Santa Clara 8
Warsaw 8
Amsterdam 7
Atlanta 7
Denver 7
Johannesburg 7
Orem 7
Princeton 7
Dong Ket 6
Paris 6
Shenyang 6
Fano 5
Gravina in Puglia 5
Hanoi 5
Milan 5
Montreal 5
Nanjing 5
Shanghai 5
Boardman 4
Buffalo 4
Chennai 4
Guangzhou 4
Manchester 4
Mexico City 4
North Bergen 4
Norwalk 4
Rio de Janeiro 4
Rome 4
San Diego 4
San Francisco 4
Ankara 3
Belo Horizonte 3
Boston 3
Columbus 3
Dearborn 3
Dhaka 3
Falkenstein 3
Grottaglie 3
Lviv 3
Miami 3
Querétaro 3
Redwood City 3
San Jose 3
The Dalles 3
Thái Bình 3
Amman 2
Baghdad 2
Barueri 2
Bauru 2
Biên Hòa 2
Brno 2
Caxias do Sul 2
Council Bluffs 2
Da Nang 2
Düsseldorf 2
Guiyang 2
Haiphong 2
Hebei 2
Imbersago 2
Totale 1.746
Nome #
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study 182
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients 162
Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort 156
Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients 148
The cost of relapsing-remitting multiple sclerosis patients who develop neutralizing antibodies during interferon beta therapy 146
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register 146
Lymphocyte count and body mass index as biomarkers of early treatment response in a multiple sclerosis dimethyl fumarate-treated cohort 137
Development and validation of the ID-EC - The ITALIAN version of the identify chronic migraine 116
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study 100
Durvalumab and multiple sclerosis: a causal link or simple unmasking? 94
Effect of cladribine on neuronal apoptosis: New insight of in vitro study in multiple sclerosis therapy 91
Personalizing Cancer Pain Therapy: Insights from the Rational Use of Analgesics (RUA) Group 91
Defining the course of tumefactive multiple sclerosis: a large retrospective multicentre study 90
Multiple Sclerosis Progression and Relapse Activity in Children 89
Magnetoencephalography and high‐density electroencephalography study of acoustic event related potentials in early stage of multiple sclerosis: A pilot study on cognitive impairment and fatigue 88
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients 82
Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis 81
Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method 81
Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing 75
Macular ganglion cell-inner plexiform layer defect patterns in multiple sclerosis patients without optic neuritis: A Spectral-Domain-Optical Coherence Tomography Cross-Sectional, Case-Control, Pilot Study 70
A case report of late-onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review 70
Impact of depression on the perception of fatigue and information processing speed in a cohort of multiple sclerosis patients 66
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany 57
Dancing With Parkinson's Disease: The SI-ROBOTICS Study Protocol 55
Risk of Getting COVID-19 in People With Multiple Sclerosis 54
Neutralizing Antibodies and Multiple Sclerosis in the Era of Disease Modifying Treatments 52
Serum neurofilament light chain in a cohort of multiple sclerosis, MOG-antibody diseases and neuromyelitis optica spectrum disorders patients 11
A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study 10
The role of serum neurofilament light chain in an adult cohort of patients with acquired demyelinating syndromes of the central nervous system (P2-4.006) 9
Totale 2.609
Categoria #
all - tutte 12.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 17 29 17 12 21 19 17
2021/2022149 13 4 2 5 8 20 5 9 10 12 27 34
2022/2023276 36 46 18 19 33 30 9 34 33 1 8 9
2023/2024110 18 17 5 15 14 15 3 6 0 7 0 10
2024/2025615 36 4 46 31 31 55 94 66 11 29 66 146
2025/2026811 213 58 104 158 200 78 0 0 0 0 0 0
Totale 2.609